VASOLYF-F-10 TAB

About

VASOLYF-F-10 is a combination medication containing Rosuvastatin and Fenofibrate, specifically formulated for the comprehensive management of mixed dyslipidemia. Rosuvastatin, a potent statin, effectively lowers elevated levels of low-density lipoprotein (LDL) cholesterol and triglycerides, while also providing a beneficial increase in high-density lipoprotein (HDL) cholesterol. Fenofibrate, a fibric acid derivative, primarily targets and significantly reduces high triglyceride levels, and also contributes to increasing HDL cholesterol, with some additional impact on LDL cholesterol. This dual-action therapy is particularly advantageous for patients who require substantial reductions in both cholesterol and triglyceride levels, especially those at high cardiovascular risk who have not achieved their target lipid profiles with monotherapy.

Uses

• Treatment of mixed dyslipidemia
• Reduction of high triglycerides
• Lowering of LDL cholesterol
• Increasing HDL cholesterol

Directions For Use

Take one tablet orally once daily, with or without food, as directed by your physician. Swallow the tablet whole.

Benefits

• Comprehensive lipid management
• Significantly lowers triglycerides
• Potently reduces LDL cholesterol
• Increases beneficial HDL cholesterol
• Reduces overall cardiovascular risk
• Effective for severe dyslipidemia

Side Effects

• Muscle pain (myalgia)
• Headache
• Nausea
• Abdominal pain
• Diarrhea
• Constipation
• Elevated liver enzymes
• Gallstones (fenofibrate)
• Pancreatitis (rare)
• Rash
• Fatigue
• Rhabdomyolysis (very rare, serious muscle breakdown)

Safety Measures

• Alcohol - Limit alcohol intake as it can increase the risk of liver problems and muscle side effects.
• Pregnancy - Contraindicated during pregnancy due to potential harm to the fetus. Use effective contraception.
• Breastfeeding - Contraindicated during breastfeeding as it may pass into breast milk and harm the infant.
• Liver - Contraindicated in active liver disease or unexplained persistent elevations of serum transaminases.
• Kidney - Contraindicated in severe renal impairment (eGFR <30 mL/min/1.73m²).
• Lung - Generally safe for use in patients with lung conditions; no specific precautions related to lung function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.